Becton Dickinson & Co (BDX): Operating Cash Flow
$3.43B
Year ended 2025-09-30
+11.6%
3-year compound annual growth
+3.2%
5-year compound annual growth
+7.1%
10-year compound annual growth
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | $3.43B | -10.8% | 2025-11-25, From 2024-10-01 |
| 2024-09-30 | $3.84B | +28.6% | 2025-11-25, From 2023-10-01 |
| 2023-09-30 | $2.99B | +21.0% | 2025-11-25, From 2022-10-01 |
| 2022-09-30 | $2.47B | -40.1% | 2024-11-27, From 2021-10-01 |
| 2021-09-30 | $4.13B | +40.5% | 2023-11-21, From 2020-10-01 |
| 2020-09-30 | $2.94B | n/a | 2022-11-22, From 2019-10-01 |
| No annual figure between 2015-09-30 and 2020-09-30. | |||
| 2015-09-30 | $1.73B | -0.9% | 2015-11-25, From 2014-10-01 |
| 2014-09-30 | $1.75B | +1.7% | 2015-11-25, From 2013-10-01 |
| 2013-09-30 | $1.72B | +1.4% | 2015-11-25, From 2012-10-01 |
| 2012-09-30 | $1.69B | +3.4% | 2014-11-26, From 2011-10-01 |
| 2011-09-30 | $1.64B | +3.2% | 2013-11-27, From 2010-10-01 |
| 2010-09-30 | $1.59B | n/c | 2012-11-21, From 2009-10-01 |
| 2009-09-30 | $1.66B | +2.5% | 2011-11-23, From 2008-10-01 |
| 2008-09-30 | $1.62B | n/c | 2010-11-24, From 2007-10-01 |
| 2007-09-30 | $1.23B | n/a | 2010-01-21, From 2006-10-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Becton Dickinson & Co (BDX) | 2025-09-30 | $3.43B | -10.8% |
| Boston Scientific Corp (BSX) | 2025-12-31 | $4.53B | +32.0% |
| 3M Co (MMM) | 2025-12-31 | $2.31B | +26.8% |
| Stryker Corp (SYK) | 2025-12-31 | $5.04B | +18.9% |
| Medline Inc. (MDLN) | 2025-12-31 | $1.74B | -1.4% |
| Baxter International Inc (BAX) | 2025-12-31 | $845.00M | -17.1% |
| Solventum Corp (SOLV) | 2025-12-31 | $369.00M | -68.9% |
| ResMed Inc (RMD) | 2026-06-30 | $1.81B | +3.1% |
| Dexcom Inc (DXCM) | 2025-12-31 | $1.44B | +45.6% |
Compare BDX, BSX, MMM, SYK side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗